Angiotensinogen 235T allele "dosage" is associated with blood pressure phenotypes

Hypertension

Volumn 41, Issue 1, 2003, Pages 25-30

  Pereira, Alexandre C ^a   Mota, Glória F A ^a   Cunha, Roberto S ^b   Herbenhoff, Fernando L ^b   Mill, José G ^b   Krieger, José E ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF ESPÍRITO SANTO   (Brazil)

Author keywords

Angiotensin converting enzyme; Angiotensinogen; Blood pressure; Genetics; Hypertension, genetic; Polymorphism

Indexed keywords

ANGIOTENSINOGEN; DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; AGE; AGED; ARTICLE; BLOOD PRESSURE REGULATION; BRAZIL; CODOMINANCE; DIABETES MELLITUS; DYSLIPIDEMIA; ETHNOLOGY; FEMALE; GENDER; GENETIC POLYMORPHISM; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SMOKING; STATISTICAL ANALYSIS;

ADULT; ALLELES; AMINO ACID SUBSTITUTION; ANGIOTENSINOGEN; BLOOD PRESSURE; CROSS-SECTIONAL STUDIES; FEMALE; GENE DOSAGE; GENE FREQUENCY; GENOTYPE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; MUTAGENESIS, INSERTIONAL; PEPTIDYL-DIPEPTIDASE A; PHENOTYPE; POLYMORPHISM, GENETIC; SEQUENCE DELETION;

EID: 0037217390     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000047465.97065.15     Document Type: Article

References (36)

1. Lifton RP, Gharavi AG, Geller DS. Molecular mechanisms of human hypertension. Cell. 2001;104:545-556.
2. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion-deletion polymorphism in the angiotensin-I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest. 1990;86:1343-1346.
3. Tiret L, Rigat B, Visvikis S, Breda C, Corvol P, Cambien F, Soubrier F. Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet. 1992;51:197-205.
4. Danser AHJ, Schalekamp MADH, Bax WA, Maasen van den Brink A, Saxena PR, Rieger GAJ, Schunkert H. Angiotensin-converting enzyme in the human heart: effect of the deletion/insertion polymorphism. Circulation. 1995;92:1387-1388.
5. Cambien F, Poirier O, Lecerf L, Evans A, Cambou JP, Arveiler D, Luc G, Bard JM, Bara L, Richard S, Tiret L, Amouyel P, Alhenc-Gelas F, Soubrier F. Deletion polymorphism in the gene for angiotensin converting enzyme is a potent risk factor for myocardial infarction. Nature. 1992;359:641-644.
6. Evans AE, Poirier O, Kee F, Lecerf L, McCrum E, Falconer T, Crane J, O'Rourke DF, Cambien F. Polymorphisms of the angiotensin-converting-enzyme gene in subjects who die from coronary heart disease. Q J Med. 1994;87:211-214.
7. Schunkert H, Hense HW, Holmer SR, Stender M, Perz S, Keil U, Lorell BH, Riegger GA. Association between a deletion polymorphism of the angiotensin-converting enzyme gene and left ventricular hypertrophy. N Engl J Med. 1994;330:1634-1638.
8. Philipp CS, Dilley A, Saidi P, Evatt B, Austin H, Zawadsky J, Harwood D, Ellingsen D, Barnhart E, Phillips DJ, Hooper WC. Deletion polymorphism in the angiotensin converting enzyme gene as a thrombophilic risk factor after hip arthroplasty. Thromb Haemost. 1998;80:869-873.
9. Schmidt S, Ritz E. Genetics of the renin-angiotensin and renal disease: a progress report. Curr Opin Nephrol Hypertens. 1997;6:146-151.
10. Jeunemaitre X, Lifton RF, Hunt SC, Williams RR, Lalouel JM. Absence of linkage between the angiotensin converting enzyme locus and human essential hypertension. Nat Genet. 1992;1:72-75.
11. Schmidt S, Van Hooft IMS, Grobbee DE, Ganten D, Ritz E. Polymorphism of the angiotensin I-converting enzyme gene is apparently not related to high blood pressure: Dutch Hypertension and Offspring Study. J Hypertens. 1993;11:345-348.
12. Crisan D, Carr J. Angiotensin I-converting enzyme: genotype and disease associations. J Mol Diagn. 2000;2:105-115.
13. Schieffer B, Drexler H. ACE gene polymorphism and coronary artery disease: a question of persuasion or statistical confusion? Arterioscler Thromb Vasc Biol. 2000;20:281-282.
14. Jeunemaitre X, Soubrier F, Kotelevtsev Y, Lifton R, Williams CS, Charru A, Hunt SC, Hopkins PN, Williams RR, Lalouel JM, Corvol P. Molecular basis of human hypertension: role of angiotensinogen. Cell. 1992;71:169-180.
15. Kunz R, Kreutz R, Beige J, Distler A, Sharma AM. Association between the angiotensinogen 235-T variant and essential hypertension in whites: a systematic review and methodological appraisal. Hypertension. 1997;30:1331-1337.
16. Tunstall-Pedoe H, for the WHO MONICA Project. The World Health Organization MONICA Project (monitoring trends and determinants in cardiovascular diseases): a major international collaboration. J Clin Epidemiol. 1988;41:105-114.
17. McKenzie K, Crowcroft NS. Ethnicity, race and culture: guidelines for research, audit and publication. BMJ. 1996;312:1094-1098.
18. Lessa I, Fonseca J. Race, compliance to treatment and/or consultation and control of arterial hypertension. Arq Bras Cardiol. 1997;68:443-449.
19. Guidelines Subcommittee. World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. J Hypertens. 1999;17:151-183.
20. Shanmugam V, Sell KW, Saha BK. Mistyping ACE heterozygotes. PCR Method Appl. 1996;3:120-121.
21. Russ AP, Maerz W, Ruzicka V, Stein U, Gross W. Rapid detection of the hypertension-associated Met235→Thr allele of the human angiotensinogen gene. Hum Mol Genet. 1993;2:609-610.
22. Kiema TR, Kauma H, Rantala AO, Lilja M, Reunanen A, Kesaniemi YA, Savolainen MJ. Variation at the angiotensin-converting enzyme gene and angiotensinogen gene loci in relation to blood pressure. Hypertension. 1996;28:1070-1075.
23. Schork NJ, Krieger JE, Troilliet MR, Franchini KG, Koike G, Krieger EM, Lander ES, Dzau VJ, Jacob HJ. A biometrical genome search in rats reveals the multigenic basis of blood pressure variation. Genome Res. 1995;5:164-172.
24. Parfrey PS, Markandu ND, Roulston JE, Jones BE, Jones JC, MacGregor GA. Relation between arterial pressure, dietary sodium intake, and renin system in essential hypertension. BMJ. 1981;283:94-97.
25. Dzau VJ. Tissue renin-angiotensin system in myocardial hypertrophy and failure. Arch Intern Med. 1993;153:937-942.
26. Wang JG, Staessen JA. Genetic polymorphisms in the renin-angiotensin system: relevance for susceptibility to cardiovascular disease. Eur J Pharmacol. 2000;410:289-302.
27. Agerholm-Larsen B, Nordestgaard BG, Steffensen R, Sorensen TIA, Jensen G, Tybjaerg-Hansen A. ACE gene polymorphismL: ischemic heart disease and longevity in 10,150 individuals. Circulation. 1997;95:2358-2367.
28. Agerholm-Larsen B, Nordestgaard BG, Tybjaerg-Hansen A. ACE gene polymorphism in cardiovascular disease: meta-analyses of small and large studies in whites. Arterioscler Thromb Vasc Biol. 2000;20:484-492.
29. Danser AHJ, Schunkert H. Renin-angiotensin system gene polymorphisms: potential mechanisms for their association with cardiovascular disease. Eur J Pharmacol. 2000;410:303-316.
30. Bohlender J, Menard J, Wagner J, Luft FC, Ganten D. Human renindependent hypertension in rats transgenic for human angiotensinogen. Hypertension. 1996;27:535-540.
31. Caulfield M, Lavender P, Newell-Price J, Kamdar S, Farral M, Clark AJL. Angiotensinogen in human essential hypertension. Hypertension. 1996;28:1123-1125.
32. Kimura S, Mullins JJ, Bunnemann B, Metzger R, Hilgenfeldt U, Zimmermann F, Jacob H, Fuxe K, Ganten D, Kaling M. High blood pressure in transgenic mice carrying the rat angiotensinogen gene. EMBO J. 1992;11:821-827.
33. Tanimoto K, Gugiyama F, Goto Y, Ishida J, Takimoto E, Yagami K Fukamizu A, Murakami K. An angiotensinogen-deficient mice with hypotension. J Biol Chem. 1994;269:31334-31337.
34. Kim HS, Krege JH, Kluckman KD, Hagaman JR, Hodgin JB, Best CF, Jennette JC, Coffman TM, Maeda N, Smithies O. Genetic control of blood pressure and the angiotensinogen locus. Proc Natl Acad Sci U S A. 1995;92:2735-2739.
35. Brand E, Chatelain N, Keavney B, Caulfield M, Citterio L, Connell J, Grobbee D, Schmidt S, Schunkert H, Schuster H, Sharma AM, Soubrier F. Evaluation of the angiotensinogen locus in human essential hypertension: a European study. Hypertension. 1998;31:725-729.
36. Sethi AA, Nordestgaard BG, Agerholm-Larsen B, Frandsen E, Jensen G, Tybjaerg-Hansen A. Angiotensinogen polymorphisms and elevated blood pressure in the general population. Hypertension. 2001;37:875-881.